Genome Editing Core Facility

Directors: Yibin Kang, PhD and Derek Sant’Angelo, PhD

Managing Director: Peter Romanienko, PhD

Scientific Director: Ghassan Yehia, PhD

In 2015 the Transgenic/Knock-out Mouse (TG/KO) Shared Resource was renamed the Genome Editing Core Facility (GECF). GECF is now an institutional core facility led by Rutgers Office of Research and Economic Development under the Office of Research Advancement (ORAd). GECF also functions as an NCI-designated cancer center resource with joint scientific and administrative/fiscal oversight with Rutgers Cancer Institute of New Jersey.

The GECF serves as one of America’s largest, most comprehensive university-based research centers. The GECF’s main facility is located in New Brunswick with a satellite site in Newark. Its main focus is to provide expertise and technical services required to manipulate the genomes of animals and various cell lines including human cells utilizing CRISPR/Cas9 mediated gene editing. Standard services such as mouse embryonic stem cell manipulation, in vitro fertilization, embryo or sperm cryopreservation, mouse rederivation, genotyping and breeding services are also offered. For additional information and to request services please visit:


The shared resources of the Rutgers Cancer Institute of New Jersey are specialized service facilities that support the cancer research efforts of our members.

The shared resources are supported in part by the Cancer Center Support Grant (CCSG) from the National Cancer Institute.  Additional support may be provided from other sources, such as chargeback systems, institutional funding and/or other grants. The support from the CCSG allows the core facilities to provide benefits to Cancer Center members, such as ensured access to services or subsidies to user rates.

Please remember to acknowledge the valuable services provided by Cancer Institute of New Jersey Shared Resources in your research papers, publications and grant applications:

"This research was supported by the [insert name(s)] Shared Resource(s) of the Rutgers Cancer Institute of New Jersey (P30CA072720)."

(Note: please also consider including the names of individuals from the shared resources if they provided any intellectual input or additional effort.)

precision medicine at Rutgers Cancer Institute


Donate Now



Proud member of
Big Ten Cancer Research Consortium



Rutgers Health